Category:

05 November 2018

FURTHER ACKNOWLEDGMENTS FOR SUCROSOMIAL IRON®

08 October 2018

NEW RECOGNITIONS TO SUCROSOMIAL IRON®

04 October 2018

NOTICE PURSUANT TO ARTICLE 17 OF AIM ITALIA ISSUER REGULATION

01 October 2018

An agreement has been signed with Fresenius Kabi for the distribution of Sucrosomial® Iron based products in Switzerland

PharmaNutra S.p.A. announces that an agreement has been firmed with Fresenius Kabi Switzerland, a company of the German multinational Fresenius […]

26 September 2018

PHARMANUTRA S.P.A.: THE RESULTS OF THE FIRST HALF CONFIRM A DOUBLE-DIGIT GROWTH

13 September 2018

PHARMANUTRA GROUP LAUNCHES FOUR NEW PRODUCTS

30 August 2018

PHARMANUTRA GROUP IS STILL GROWING ON THE ITALIAN MARKET

08 August 2018

PHARMANUTRA CONFERMA LA TITLE SPONSORSHIP CON IL PARMA CALCIO 1913

26 July 2018

PHARMANUTRA: REVENUES FOR THE FIRST HALF OF 2018 UP BY 20%. THE GROUP STRENGTHENS ITS INTERNATIONAL PRESENCE

18 July 2018

PHARMANUTRA: GROWTH IN BUSINESS AND VALUE ONE YEAR FROM LISTING ON THE STOCK EXCHANGE

11 July 2018

ULTRAMAG: SUCROSOMIAL TECHNOLOGY REVOLUTIONISES THE MAGNESIUM MARKET

05 July 2018

PHARMANUTRA TAKES CENTRE STAGE AT THE “HEALTHCARE FORUM” AT THE BORSA ITALIANA

04 July 2018

PHARMANUTRA PARTICIPATES IN THE “HEALTH CARE FORUM” IN BORSA ITALIANA

03 July 2018

PHARMANUTRA: FRANCESCO SARTI APPOINTED CHIEF FINANCIAL OFFICER OF THE GROUP

28 June 2018

PHARMANUTRA: NEW SALES RECORD IN MAY

28 May 2018

NEW COMMERCIAL AGREEMENTS SIGNED FOR THE DISTRIBUTION OF SUCROSOMIAL® IRON ABROAD

23 April 2018

PHARMANUTRA: SHAREHOLDERS’ MEETING OF 23 APRIL 2018

11 April 2018

6TH INTERNATIONAL MULTIDISCIPLINARY COURSE ON IRON DEFICIENCY (IMCID)

06 April 2018

PHARMANUTRA OBTAINS A PATENT FOR CETILAR® RM

27 March 2018

PHARMANUTRA: SUCROSOMIAL® IRON CHOSEN AS PRODUCT OF THE YEAR BY ISRAELI CONSUMERS

20 March 2018

PHARMANUTRA: THE BOARD OF DIRECTORS APPROVES THE DRAFT SEPARATE AND CONSOLIDATED FINANCIAL STATEMENTS AS OF AND FOR THE YEAR ENDED 31 DECEMBER 2017